Target intelligence / Profile preview

ribosomal protein L9 pseudogene 13 (RPL9P13)

Target
RPL9P13
Molecular classification
Other (processed pseudogene; non-coding genomic element)
01

Overview

RPL9P13 is a processed pseudogene derived from the ribosomal protein L9 gene (RPL9), found in the human genome[2]. Unlike the functional RPL9 gene, which encodes a component of the 60S ribosomal subunit and is associated with protein synthesis and certain diseases like Diamond-Blackfan anemia[1], RPL9P13 does not code for a functional protein and does not serve as a target for drugs or have biological activity. Pseudogenes like RPL9P13 are remnants of genes that lost their protein-coding potential due to mutations or genome rearrangements. They are often cataloged in genomic databases, but do not serve as therapeutic targets, biomarkers, or safety concerns for drug development or clinical practice[2]. If you need information about functional ribosomal proteins, such as ribosomal protein L9 (RPL9), these are legitimate molecular targets with established biological roles[1]. However, RPL9P13 is not a therapeutic or biological target; it is a nonfunctional pseudogene.

Other names
RPL9P13RPL9_2_278

Beyond the preview

Go deeper on ribosomal protein L9 pseudogene 13 (RPL9P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L9 pseudogene 13 (RPL9P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call